300 related articles for article (PubMed ID: 33421304)
1. Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia.
Aung MMK; Mills ML; Bittencourt-Silvestre J; Keeshan K
Mol Oncol; 2021 Sep; 15(9):2253-2272. PubMed ID: 33421304
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics of paediatric acute myeloid leukaemia.
Jones L; McCarthy P; Bond J
Br J Haematol; 2020 Jan; 188(1):63-76. PubMed ID: 31804725
[TBL] [Abstract][Full Text] [Related]
3. Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy.
Ragusa M; Avola G; Angelica R; Barbagallo D; Guglielmino MR; Duro LR; Majorana A; Statello L; Salito L; Consoli C; Camuglia MG; Di Pietro C; Milone G; Purrello M
BMC Cancer; 2010 Jul; 10():377. PubMed ID: 20642818
[TBL] [Abstract][Full Text] [Related]
4. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
Laing AA; Harrison CJ; Gibson BES; Keeshan K
Exp Hematol; 2017 Oct; 54():40-50. PubMed ID: 28668350
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia.
Palma CA; Al Sheikha D; Lim TK; Bryant A; Vu TT; Jayaswal V; Ma DD
Mol Cancer; 2014 Apr; 13():79. PubMed ID: 24708856
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
[TBL] [Abstract][Full Text] [Related]
7. Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia.
Brown FC; Cifani P; Drill E; He J; Still E; Zhong S; Balasubramanian S; Pavlick D; Yilmazel B; Knapp KM; Alonzo TA; Meshinchi S; Stone RM; Kornblau SM; Marcucci G; Gamis AS; Byrd JC; Gonen M; Levine RL; Kentsis A
Br J Haematol; 2017 Jan; 176(1):86-91. PubMed ID: 27766616
[TBL] [Abstract][Full Text] [Related]
8. A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis.
Morris VS; Ghazi H; Fletcher DM; Guinn BA
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298623
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
[TBL] [Abstract][Full Text] [Related]
10. Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias.
Chaudhury S; O'Connor C; Cañete A; Bittencourt-Silvestre J; Sarrou E; Prendergast Á; Choi J; Johnston P; Wells CA; Gibson B; Keeshan K
Nat Commun; 2018 Dec; 9(1):5280. PubMed ID: 30538250
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Grove CS; Vassiliou GS
Dis Model Mech; 2014 Aug; 7(8):941-51. PubMed ID: 25056697
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach.
Cheng PL; Hsiao TH; Chen CH; Hung MN; Jhan PP; Lee LW; Wu TS; Tsai JR; Teng CJ
Hematol Oncol; 2023 Aug; 41(3):499-509. PubMed ID: 36790759
[TBL] [Abstract][Full Text] [Related]
14. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic & prognostic role of microRNAs in paediatric acute myeloid leukaemia.
Kumar S; Bakhshi S
Indian J Med Res; 2016 Dec; 144(6):807-814. PubMed ID: 28474617
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers in acute myeloid leukaemia.
Kühnl A; Grimwade D
Int J Hematol; 2012 Aug; 96(2):153-63. PubMed ID: 22791509
[TBL] [Abstract][Full Text] [Related]
17. Detection of continuous hierarchical heterogeneity by single-cell surface antigen analysis in the prognosis evaluation of acute myeloid leukaemia.
Shao N; Ren C; Hu T; Wang D; Zhu X; Li M; Cheng T; Zhang Y; Zhang XE
BMC Bioinformatics; 2023 Nov; 24(1):450. PubMed ID: 38017410
[TBL] [Abstract][Full Text] [Related]
18. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
19. Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics.
Gregory TK; Wald D; Chen Y; Vermaat JM; Xiong Y; Tse W
J Hematol Oncol; 2009 Jun; 2():23. PubMed ID: 19490647
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
Miyamura T; Moritake H; Nakayama H; Tanaka S; Tomizawa D; Shiba N; Saito AM; Tawa A; Shimada A; Iwamoto S; Hayashi Y; Koike T; Horibe K; Manabe A; Mizutani S; Taga T; Adachi S
Br J Haematol; 2019 Apr; 185(2):284-288. PubMed ID: 30784060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
